RNAIII-activating protein (RAP)

RNAIII-activating protein (RAP) is a 33-kDa protein secreted by Staphylococcus aureus that serves as a critical autoinducer in the bacteria's quorum-sensing network (Balaban et al., 1998, Science). RAP functions by inducing the phosphorylation of its receptor, the Target of RNAIII-activating protein (TRAP), which is a 21-kDa membrane-associated protein (Gov et al., 2001, J. Biol. Chem.). This phosphorylation event is essential for the activation of the accessory gene regulator (agr) locus, leading to the synthesis of RNAIII, the primary effector molecule that upregulates the expression of numerous exotoxins and degradative enzymes while downregulating surface adhesion proteins (Novick et al., 1993, EMBO J.). Because RAP is central to the transition of S. aureus from a colonizing state to an invasive, pathogenic state, it is a major target for anti-virulence therapeutic strategies. Drugs such as the RNAIII-inhibiting peptide (RIP) and small molecules like hamamelitannin work by competitively inhibiting the RAP/TRAP signaling axis, thereby attenuating the pathogenicity of the bacteria without exerting the direct selective pressure for resistance associated with traditional antibiotics (Balaban et al., 2000, Peptides; Kiran et al., 2008, J. Infect. Dis.). This approach is particularly relevant for managing multi-drug resistant strains like MRSA and biofilm-associated infections where conventional therapy often fails.

Other names

RAPStaphylococcal RNAIII-activating proteinRNAIII-activating protein of Staphylococcus aureus

Inhibition of RAP-mediated phosphorylation of the Target of RNAIII-activating protein (TRAP), which prevents the activation of the accessory gene regulator (agr) system and the subsequent production of RNAIII and virulence factors.